Comments
Loading...

Foghorn Therapeutics

FHTXNASDAQ
Logo brought to you by Benzinga Data
$9.56
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$20.00
Lowest Price Target1
$6.00
Consensus Price Target1
$15.63

Foghorn Therapeutics (NASDAQ:FHTX) Stock, Analyst Ratings, Price Targets, Forecasts

Foghorn Therapeutics Inc has a consensus price target of $15.63 based on the ratings of 8 analysts. The high is $20 issued by Evercore ISI Group on August 19, 2024. The low is $6 issued by Morgan Stanley on November 13, 2023. The 3 most-recent analyst ratings were released by Jefferies, Evercore ISI Group, and HC Wainwright & Co. on September 3, 2024, August 19, 2024, and August 12, 2024, respectively. With an average price target of $19.33 between Jefferies, Evercore ISI Group, and HC Wainwright & Co., there's an implied 102.23% upside for Foghorn Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
2
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jefferies
Evercore ISI Group
HC Wainwright & Co.
Wedbush
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Foghorn Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Foghorn Therapeutics (FHTX) stock?

A

The latest price target for Foghorn Therapeutics (NASDAQ:FHTX) was reported by Jefferies on September 3, 2024. The analyst firm set a price target for $18.00 expecting FHTX to rise to within 12 months (a possible 88.28% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Foghorn Therapeutics (FHTX)?

A

The latest analyst rating for Foghorn Therapeutics (NASDAQ:FHTX) was provided by Jefferies, and Foghorn Therapeutics initiated their buy rating.

Q

When was the last upgrade for Foghorn Therapeutics (FHTX)?

A

There is no last upgrade for Foghorn Therapeutics

Q

When was the last downgrade for Foghorn Therapeutics (FHTX)?

A

The last downgrade for Foghorn Therapeutics Inc happened on August 24, 2022 when Morgan Stanley changed their price target from $25 to $15 for Foghorn Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Foghorn Therapeutics (FHTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Foghorn Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Foghorn Therapeutics was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Foghorn Therapeutics (FHTX) correct?

A

While ratings are subjective and will change, the latest Foghorn Therapeutics (FHTX) rating was a initiated with a price target of $0.00 to $18.00. The current price Foghorn Therapeutics (FHTX) is trading at is $9.56, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch